Dominant-negative Stat5 inhibits growth and induces apoptosis in T47D-derived tumors in nude mice - PubMed (original) (raw)

Dominant-negative Stat5 inhibits growth and induces apoptosis in T47D-derived tumors in nude mice

Hiroko Yamashita et al. Cancer Sci. 2004 Aug.

Abstract

Signal transducer and activator of transcription 5 (Stat5) regulates growth, differentiation, and survival of mammary and hematopoietic cells. The role of Stat5 in breast cancer has not been established, although Stat5 is critical for some hematopoietic malignancies. In this study, we have analyzed the role of Stat5 in progression of the estrogen receptor-positive T47D human breast cancer cell line, in which Stat5b is constitutively activated. Expression of Stat5-regulated genes, such as cyclin D1 and bcl-xL, was strongly suppressed in T47D cells infected with the dominant-negative Stat5 adenovirus, AdStat5aDelta740. We also determined the phenotypic effects of introduction of dominant-negative Stat5 on T47D-derived tumors in nude mice. Tumors injected with AdStat5aDelta740 showed a 60% reduction in size, which was associated with the induction of apoptosis. Our results indicate the possibility of using dominant-negative Stat5 to induce apoptosis in certain Stat5-activated breast cancers.

PubMed Disclaimer

Similar articles

• Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells.
  Yamashita H, Iwase H, Toyama T, Fujii Y. Yamashita H, et al. Oncogene. 2003 Mar 20;22(11):1638-52. doi: 10.1038/sj.onc.1206277. Oncogene. 2003. PMID: 12642867
• The role of Stat5 in estrogen receptor-positive breast cancer.
  Yamashita H, Iwase H. Yamashita H, et al. Breast Cancer. 2002;9(4):312-8. doi: 10.1007/BF02967610. Breast Cancer. 2002. PMID: 12459712
• Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
  Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B, Skorski T. Nieborowska-Skorska M, et al. J Exp Med. 1999 Apr 19;189(8):1229-42. doi: 10.1084/jem.189.8.1229. J Exp Med. 1999. PMID: 10209040 Free PMC article.
• The STATs of cancer--new molecular targets come of age.
  Yu H, Jove R. Yu H, et al. Nat Rev Cancer. 2004 Feb;4(2):97-105. doi: 10.1038/nrc1275. Nat Rev Cancer. 2004. PMID: 14964307 Review. No abstract available.
• Stat5: an essential regulator of mast cell biology.
  Shelburne CP, McCoy ME, Piekorz R, Sexl VV, Gillespie SR, Bailey DP, Gharse A, Mirmonsef P, Mann MN, Kashyap M, Wright HV, Chong HJ, Bouton LA, Ramirez CD, Lantz CS, Ryan JJ. Shelburne CP, et al. Mol Immunol. 2002 Sep;38(16-18):1187-91. doi: 10.1016/s0161-5890(02)00061-5. Mol Immunol. 2002. PMID: 12217382 Review.

Cited by

• Dexamethasone inhibits camptothecin-induced apoptosis in C6-glioma via activation of Stat5/Bcl-xL pathway.
  Qian YH, Xiao Q, Chen H, Xu J. Qian YH, et al. Biochim Biophys Acta. 2009 May;1793(5):764-71. doi: 10.1016/j.bbamcr.2009.01.017. Epub 2009 Feb 7. Biochim Biophys Acta. 2009. PMID: 19339209 Free PMC article.
• Androgen-regulated and highly tumorigenic human prostate cancer cell line established from a transplantable primary CWR22 tumor.
  Dagvadorj A, Tan SH, Liao Z, Cavalli LR, Haddad BR, Nevalainen MT. Dagvadorj A, et al. Clin Cancer Res. 2008 Oct 1;14(19):6062-72. doi: 10.1158/1078-0432.CCR-08-0979. Clin Cancer Res. 2008. PMID: 18829484 Free PMC article.
• Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression.
  Wagner KU, Rui H. Wagner KU, et al. J Mammary Gland Biol Neoplasia. 2008 Mar;13(1):93-103. doi: 10.1007/s10911-008-9062-z. Epub 2008 Jan 29. J Mammary Gland Biol Neoplasia. 2008. PMID: 18228120 Review.
• Predictors of response to exemestane as primary endocrine therapy in estrogen receptor-positive breast cancer.
  Yamashita H, Takahashi S, Ito Y, Yamashita T, Ando Y, Toyama T, Sugiura H, Yoshimoto N, Kobayashi S, Fujii Y, Iwase H. Yamashita H, et al. Cancer Sci. 2009 Nov;100(11):2028-33. doi: 10.1111/j.1349-7006.2009.01274.x. Epub 2009 Jul 6. Cancer Sci. 2009. PMID: 19659610 Free PMC article.
• Nucleic acid-based approaches to STAT inhibition.
  Sen M, Grandis JR. Sen M, et al. JAKSTAT. 2012 Oct 1;1(4):285-91. doi: 10.4161/jkst.22312. JAKSTAT. 2012. PMID: 24058785 Free PMC article. Review.

References

1. 1. Hennighausen L, Robinson GW, Wagner KU, Liu W. Prolactin signaling in mammary gland development. J Biol Chem 1997; 272: 7567–9. - PubMed
2. 1. Watson CJ. Stat transcription factors in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 2001; 6: 115–27. - PubMed
3. 1. Grimley PM, Dong F, Rui H. Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev 1999; 10: 131–57. - PubMed
4. 1. Bromberg J. Stat proteins and oncogenesis. J Clin Invest 2002; 109: 1139–42. - PMC - PubMed
5. 1. Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 2002; 8: 945–54. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Wiley

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal